Glucotrack (Nasdaq:GCTK) announced today that it submitted its implantable continuous blood glucose monitor (CBGM) for FDA ...

Blood glucose levels can be a reliable indicator of diabetes risk. But in some populations, it's not enough to catch the ...

Landmark 10th Annual Awards Program Recognizes the Most Innovative Digital Health and Medical Technology Solutions Worldwide ...

Continuous glucose monitoring (CGM) devices are seeing rapid adoption, supported by clinical evidence, updated guidelines, and growing consumer interest beyond traditional diabetes care. Studies show ...

While GLP-1 agonists have grabbed investor attention for their potential as weight loss aids, these medicines also form a ...

DexCom has a well-established record of introducing the most precise sensors for use in its continuous glucose monitors. On the strength of its technology, DexCom has captured an impressive slice of ...

Medical device maker Dexcom on Thursday reiterated its full-year revenue forecast after beating Wall Street estimates for ...

Abstract: Glucose monitoring plays a vital role in maintaining metabolic and nutritional balance. However, invasive methods, while accurate, are often painful and impractical for routine use. This ...

Equity-Insider.com News Commentary – Here's the quiet shift in medtech right now: the global medical imaging market is on track to grow from $41.64 billion in 2024 to $67.87 billion by 2034 [1], and ...

The Middle East and Africa Continuous Glucose Monitoring (CGM) market is set for growth, driven by increasing diabetes rates, technological advancements, and healthcare awareness. Projected to rise ...

MiniMed (Nasdaq:MMED) announced today that it received approval in Canada for new software for its MiniMed 780G system.